COMMON VARIABLE IMMUNODEFICIENCY (CVID)

 

COMMON VARIABLE IMMUNODEFICIENCY (CVID)

 

DEFINITION:

A heterogeneous group of B-cell disorders characterized by hypogammaglobulinemia resulting in the late onset of recurrent sino-pulmonary and gastrointestinal infections.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • 2nd and 3rd decades; rarely before 6 years of age
  • risk factors:
    • familial - autosomal recessive and dominant forms
      • chrom.#: ?
      • gene: ?
    • M = F

PATHOGENESIS:

1. Etiology

1. Hereditary Predisposition

  • autosomal recessive and dominant forms
  • increased incidence of hypogammaglobulinemia, Selective IgA Deficiency, autoimmune disease, and neoplasms among first degree relatives

2. Acquired

  • may also be acquired forms

2. Defect

  • hypothesized that a variety of factors (hereditary and acquired) result in the failure of B cells to undergo terminal plasma cell differentiation and/or to secrete immunoglobulins -> humoral-me-iated immunodeficiency -> persistent infections by encapsulated bacteria (H. flu, pneumococcus, staphylococcus), mycoplasma, or ureaplasma
  • the differentiation of B-cells into antibody-secreting cells may be blocked at any number of sites
  • may represent a heterogeneous group of disorders where the B cells fail to receive or respond to normal maturational signals as B-cells from patients with CVID have the capacity to differen-tiate into plasma cells when exposed to an appropriate set of stimuli in vitro
  • apart from a later onset, the clinical manifestations of CVID may be indistinguishable from those of Bruton Disease

CLINICAL FEATURES:

1. Immunodeficiency Manifestations

1. Respiratory

1. Sinopulmonary Infections (90%)

  • may be chronic and recurrent
  • paranasal sinusitis, bronchitis, chronic cough
  • chronic otitis media (30%)

2. Serious Pulmonary Involvement

  • 30-40% progress to develop serious pulmonary involvement
  • pneumonia
  • interstitial fibrosis
  • panlobular emphysema
  • chronic lung disease
  • chronic progressive bronchiectasis

2. Gastrointestinal

1. Chronic Diarrhea (60%) +/-

  • malabsorption (vitamin B12) +/- steatorrhea
  • protein-loosing enteropathy
  • giardiasis (35-65%)
  • clostridium difficle (24%)

2. Others

  • bacterial overgrowth, disaccharidase deficiency, jejunal villous atrophy, lactose intolerance, Nodular
  • Lymphoid Hyperplasia

2. Complications

1. Autoimmune Disorders

  • hemolytic anemia, pernicious anemia (5%), autoimmune neutro-penia
  • Rheumatoid Arthritis, SLE, ITP, Dermatomyositis, Scleroder-ma, Chronic Active Hepatitis

2. Neoplasms

  • present in the 5th to 6th decades
  • reticuloendothelial tumors (lymphomas)
  • stomach cancer

3. Infectious

  • noncaseating granulomas of the lungs, spleen, liver, skin
  • vaccine-associated poliomyelitis
  • infectious mononucleosis
  • echovirus meningoencephalitis and dermatomyositis

4. Others

  • nondeforming polyarthritis and/or polyarthralgias
  • Amyloidosis
  • Hemolytic Uremic Syndrome
  • cutaneous anergy (in up to 50% of cases)

INVESTIGATIONS:

1. Serum

1. Humoral-Mediated

  • variable number of circulating B-cells from decreased to increased (there are only a few circulating immature B-cells in Bruton Disease)
  • proliferating B-cells may cause splenomegaly, hepatomegaly, and hypertrophy of lymph nodes & intestinal lymphoid tissue - absence of plasma cells in some lymphoid tissues (lymph nodes, bone marrow, tonsils, spleen)
  • reduced levels of IgG, IgA, and IgM (IgM tends to be less affected)
  • diverse expression of surface immunoglobulins on B-cells
  • increased incidence of autoantibodies (rheumatoid factor, anti-RBC antibodies, antibodies to T- or B-cells)
  • markedly reduced antibody response on challenge with a variety of antigens

2. Cell-Mediated

  • normal number and function of T cells, i.e., initially there is normal cell-mediated immunity
  • normal CD4+ T Helper Cell number and function
  • normal or increased CD8+ T Suppressor Cell number
  • as patients age, significant T-cell abnormalities may develop

3. CBC

  • pancytopenia - anemia (40%), leukopenia, lymphopenia
  • anemia may be due to folate or Vitamin B12 malabsorption

MANAGEMENT:

1. Supportive

  • antibiotics for specific infections
  • flagyl for giardiasis
  • corticosteroids for noncaseating granulomas
  • follow for the development of autoimmune disorders or other complications and treat any that develop

2. Immunosuppression

1. Intravenous Immunoglobulin (IV IgG)

  • 0.1-0.6 g/kg/month
  • indications:
    • severe sinopulmonary infections
    • echovirus-induced meningoencephalitis and dermatomyo-sitis
    • polyarthritis and/or polyarthralgia

2. Cimetidine

  • may reverse T Suppressor activity and subsequently increase serum IgG levels

3. Prognosis

  • increased mortality especially from late-onset malignancies

 

 

 

Pediatric Database - COMMON VARIABLE IMMUNODEFICIENCY (CVID)

Pediatric Organization - Pedbase [at] Gmail.com